Errata “Antenatal Corticosteroids Prior to 24 Weeks' Gestation and Neonatal Outcome of Extremely Low Birth Weight Infants”

Table of Contents

The publisher regrets an error in the table titles of Tables [1] and [2] in the above article in the American Journal of Perinatology, Volume 27, Number 1, 2010, p. 63. The correct tables appear below.

Table 1 Maternal and Delivery Characteristics of Singleton Pregnancies Delivered at 23⁰/₇ to 25⁶/₇ Weeks' Gestation

Characteristics	Steroid-Treated (n = 82)	Controls (n = 35)	p Value
Maternal age (y)	28.7 ± 7.1	26.9 ± 7.2	0.22
Black/white/other (%)	65/23/13	66/17/17	0.90
Preeclampsia (%)	9.8	2.9	0.37
Preterm labor (%)	77.8	68.9	0.61
Chorioamnionitis (%)	76.8	54.3	0.03
Premature rupture of membranes (%)	59.8	34.3	0.02
Cesarean section (%)	47.6	40.0	0.58
Gestational age at ANS dose (wk)	23.5 ± 0.5
Data expressed as percentage and mean ± standard deviation. ANS, antenatal corticosteroid.

Table 2 Antenatal Corticosteroid Exposure: Outcome of Singleton Infants at 23⁰/₇ to 25⁶/₇ Weeks' Gestation

Characteristics	Steroid-Treated (n = 82)	Controls (n = 35)	p Value
Birth weight (g)	702 ± 165	657 ± 150	0.14
Gestational age (wk)	24.3 ± 1.0	24.1 ± 1.1	0.30
Sex (% male/female)	54.9/45.1	57.1/42.9	0.84
1-min Apgar <7 (%)	68.3	88.6	0.02
5-min Apgar <7 (%)	30.5	51.4	0.03
Death before discharge (%)	29.3	62.9	<0.001
IVH (grade 1 and 2, %)	45.5	43.5	0.99
IVH (grade 3 and 4, %)	16.7	36.0	<0.05
RDS (%)	100	100	NA
PDA treated with indomethacin (%)	50.7	72.0	0.07
Sepsis (%)	60.7	52.2	0.48
NEC stage 3 and 4 (%)	0.0	6.9	0.57
Pressors (%)	54.4	64.5	0.35
ROP (stage 3–4)	32.7	23.1	0.74
BPD at 36 weeks' PCA (%)	71.9	76.9	0.99
Duration of vent (d)	51 ± 37	49 ± 21	0.80
Duration of O2 (d)	55 ± 38	53 ± 38	0.72
Length of stay (d)	117 ± 52	108 ± 24	0.41
Data expressed as percentage and mean ± SD.
PDA, patent ductus arteriosus; NEC, necrotizing enterocolitis; IVH, intraventricular hemorrhage; ROP, retinopathy of prematurity; BPD, bronchopulmonary dysplasia; PCA, postconceptional age.